CVS Health (NYSE:CVS) Stock Rating Upgraded by Wall Street Zen

CVS Health (NYSE:CVS) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Tuesday.

A number of other equities analysts also recently issued reports on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of CVS Health in a report on Friday, May 8th. Truist Financial upped their price objective on shares of CVS Health from $102.00 to $108.00 and gave the stock a “buy” rating in a report on Monday, June 1st. Robert W. Baird increased their target price on CVS Health from $92.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Bank of America boosted their price objective on CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, June 22nd. Finally, Barclays lifted their target price on CVS Health from $101.00 to $106.00 and gave the company an “overweight” rating in a research note on Tuesday, May 26th. Twenty-one equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $102.60.

CVS Health Trading Up 1.7%

Shares of CVS traded up $1.74 during trading hours on Tuesday, reaching $103.82. 292,579 shares of the company traded hands, compared to its average volume of 8,467,340. CVS Health has a 12 month low of $58.50 and a 12 month high of $106.15. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. The company’s fifty day moving average price is $94.56 and its two-hundred day moving average price is $83.31. The company has a market capitalization of $132.46 billion, a price-to-earnings ratio of 45.76, a price-to-earnings-growth ratio of 1.03 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The business had revenue of $100.43 billion for the quarter, compared to analysts’ expectations of $94.99 billion. During the same period in the previous year, the firm posted $2.25 EPS. The business’s revenue was up 6.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Equities research analysts predict that CVS Health will post 7.44 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, EVP Tilak Mandadi sold 69,551 shares of CVS Health stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $89.58, for a total value of $6,230,378.58. Following the transaction, the executive vice president owned 10,133 shares of the company’s stock, valued at $907,714.14. The trade was a 87.28% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Larry Robbins sold 1,983,538 shares of the firm’s stock in a transaction dated Tuesday, May 19th. The stock was sold at an average price of $94.45, for a total value of $187,345,164.10. Following the completion of the sale, the director directly owned 6,213,261 shares of the company’s stock, valued at approximately $586,842,501.45. This represents a 24.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 3,441,551 shares of company stock valued at $323,703,977. 0.85% of the stock is owned by company insiders.

Institutional Trading of CVS Health

A number of hedge funds and other institutional investors have recently modified their holdings of CVS. Norges Bank purchased a new stake in CVS Health in the fourth quarter valued at approximately $1,666,265,000. Wellington Management Group LLP boosted its holdings in shares of CVS Health by 193.2% in the fourth quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock valued at $1,473,270,000 after acquiring an additional 12,233,675 shares during the period. Pacer Advisors Inc. raised its position in CVS Health by 1,020.7% in the 1st quarter. Pacer Advisors Inc. now owns 4,845,221 shares of the pharmacy operator’s stock valued at $347,984,000 after purchasing an additional 4,412,882 shares during the last quarter. Amundi boosted its stake in CVS Health by 95.3% during the 3rd quarter. Amundi now owns 7,453,980 shares of the pharmacy operator’s stock worth $572,665,000 after purchasing an additional 3,637,943 shares during the period. Finally, Capital Research Global Investors increased its stake in CVS Health by 24.5% in the third quarter. Capital Research Global Investors now owns 11,469,250 shares of the pharmacy operator’s stock valued at $864,667,000 after purchasing an additional 2,253,531 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Cantor Fitzgerald raised its price target on CVS Health to $110 and maintained an overweight rating, signaling confidence in the company’s outlook and supporting the stock. Benzinga article
• Positive Sentiment: Recent commentary highlighted CVS Health as a momentum name and a healthcare outlier, with investors focused on its earnings beat, margin expansion potential, and turnaround progress. Seeking Alpha article
• Positive Sentiment: CVS Health Foundation announced a $1 million investment in Hartford nonprofits, which may modestly support the company’s community health image and ESG profile. Yahoo Finance article
• Neutral Sentiment: CVS Health said it will hold its second-quarter 2026 earnings conference call on August 5, keeping investors focused on upcoming results rather than changing fundamentals immediately. PR Newswire article
• Negative Sentiment: CVS medicated wipes were recalled over child safety concerns, a consumer-safety issue that could create reputational noise and weigh on sentiment. WBIW article
• Negative Sentiment: A separate report also noted the medicated wipes recall tied to child safety concerns, reinforcing the product-liability overhang. Yahoo News article

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.